Last reviewed · How we verify

NCT04258891: DYNAKT

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

Completed Last updated 16 September 2020
What this trial tests

trial testing No intervention in Kidney Transplant Failure in 14,000 participants. Completed in 30 June 2020.

Timeline
1 January 2004
Primary endpoint
31 December 2019
30 June 2020

Quick facts

Lead sponsorParis Translational Research Center for Organ Transplantation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment14,000
Start date1 January 2004
Primary completion31 December 2019
Estimated completion30 June 2020
Sites18 locations across France, Chile, Argentina, Spain, Croatia, United States, Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Paris Translational Research Center for Organ Transplantation — full company profile →

Who can join

18 and older, any sex, with Kidney Transplant Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The incidence of end stage renal disease (ESRD) is rapidly increasing, now affecting an estimated 7.4 million people worldwide. Numerous parameters such as demographic, clinical and functional factors drive the deterioration of the kidney, ultimately leading to ESRD. Although some ESRD prediction models have been derived in the past years, none of these models are dynamic: they do not integrate the repeated measurements recorded throughout individuals' follow-up. As highlighted in several studies, kidney function repeated measurements (i.e., trajectories) are highly associated with graft survival after kidney transplantation. The investigators made the hypothesis that these trajectories may bring relevant information in the context of graft survival risk prediction model. Hence, combining these trajectories with standard graft survival risk factors may enhance prediction performance. This could permit to derive a robust tool that could be updated over time by continuously capturing patient' personal evolution.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study.
    Raynaud M, Aubert O, Divard G, Reese PP, et al · · 2021 · cited 51× · PMID 34756569 · DOI 10.1016/s2589-7500(21)00209-0
  2. Dynamic prediction of renal survival using artificial intelligence: an international study of deeply phenotyped cohorts of kidney transplant recipients
    Loupy A, Raynaud M, Aubert O, Reese PP, et al · · 2020 · DOI 10.21203/rs.3.rs-85478/v1

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Kidney Transplant Failure

Currently open trials in the same condition.

Other Paris Translational Research Center for Organ Transplantation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04258891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing